On February 28, 2025, the Company completed its sale of the Statesman. As a result of the sale, we recognized a pre-tax gain of approximately $20.8 million, net of selling expenses, which is included in Loss (gain) on sale or disposal of assets, net in the condensed consolidated statement of operations and comprehensive income (loss) for the six months ended June 30,

Cash equivalents represent highly liquid certificates of deposit which have original maturities of three months or less. Restricted cash is held as cash collateral for certain business operations. Restricted cash primarily consists of funding for letters of credit, cash held in an irrevocable grantor trust for our deferred compensation plans and cash held with banking institutions for insurance.

The following table presents a reconciliation of cash, cash equivalents and restricted cash:


In thousands	June 30, 2026		June 30, 2025
Cash and cash equivalents	$	86,657	$	88,542
Restricted cash included in other current assets	21		76
Restricted cash included in pension and other assets	7,564		7,547
Total cash, cash equivalents and restricted cash	$	94,242	$	96,165

The following table presents supplemental cash flow information, including non-cash investing and financing activities:


	Six months ended June 30,
In thousands	2026		2025
Cash paid for taxes, net of refunds	$	5,434	$	1,237
Cash paid for interest	38,965		40,155
Non-cash investing and financing activities:
Accrued capital expenditures	$	17,320	$	29,047


In thousands	June 30, 2026		December 31, 2025
Accounts payable	$	145,766	$	144,401
Compensation	60,111		79,505
Taxes (primarily property, sales, and payroll taxes)	9,272		8,693
Benefits	20,738		19,985
Interest	8,274		8,972
Other	43,859		46,596
Accounts payable and accrued liabilities	$	288,020	$	308,152